21 -12 (50) 2022 — Abduazizova N.X., Xidoyatova M.R. — THE DEBUT OF RHEUMATOID ARTHRITIS IN THE ELDERLY PERSONS

THE DEBUT OF RHEUMATOID ARTHRITIS IN THE ELDERLY PERSONS

Abduazizova N.X., Tashkent medical academy Uzbekistan

Xidoyatova M.R., Tashkent medical academy Uzbekistan

Sharapov Z.A., Tashkent medical academy Uzbekistan

Solixov B.M., Tashkent medical academy Uzbekistan

Jaksыmuratova X.T. Tashkent medical academy Uzbekistan

Resume

At present time genetic mechanisms of rheumatoid arthritis were studied more widely then other mechanisms, for example pathological changes in elder age which playing role in pathogenesis and progress of deasease are out of field of view. Early diagnosis of rheumatoid artritis in elder age allows to add corrections to manegment. 

Key words: rheumatoid arthritis, elderly age, treatmant

First page

131

Last page

133

For citation: Abduazizova N.X., Xidoyatova M.R., Sharapov Z.A., Solixov B.M., Jaksыmuratova X.T. THE DEBUT OF RHEUMATOID ARTHRITIS IN THE ELDERLY PERSONS //New Day in Medicine 12(50)2022 https://clck.ru/3379tQ

LIST OF REFERENCES:

  1. Балабанова Р.М., Каптаева А.К. Особенности клинической картины и лечения ревматоидного артрита в пожилом возрасте. Consilium Medicum. 2006; (12):12-82.
  2. Бочкова АГ. Ревматоидный артрит с дебютом в пожилом возрасте: течение и терапия. Клиническая геронтология. 2002; 8(3):45-50.
  3. Еламщва И.Ж. Врачебно-трудовая экспертиза больных ревматоидным артритом. Материалы научно-практической конференции. Ташкент, 1990. – С. 40-45.
  4. Елисеев М.С., Желябина О.В., Чикина М.Н. и др. Влияние терапии на субклинический атеросклероз сонных артерий у пациентов с болезнью депонирования кристаллов пирофосфатов кальция и остеоартритом (пилотное исследование). //Научно-практическая ревматология журнал – 2021. –Том:59 –№6. –С.708-714.
  5. Сатыбалдыев А.М. Ревматоидный артрит у пожилых. Consilium Medicum.2007;9(12):85-92. [Satybaldyev AM. Rheumatoid arthritis in elderly. //Consilium Medicum. 2007;9(12):85-92. (In Russ.)].
  6. Haye-Salinas M.J., Bertoli A.M., Lema L., Saucedo C., Rosa J., Quintana R. et al. Prevalence of dyslipidemia and elevated cardiovascular risk in patients with rheumatoid arthritis. //Medicina (B Aires) 2013; 73(1):26–30. [PubMed] [Google Scholar].
  7. Nargiza Abduazizova., Sevara Mukhammadieva, Elnora Djurayeva., Gulnoza Rakhmatullaeva. Lipid profile in patients with rheumatoid arthritis on thebackground of basic treatment //International Journal of Early Childhood Special Education (INT-JECSE)DOI: 10.9756/INT-JECSE/V14I1.382 ISSN: 1308-5581 Vol 14, Issue 01 2022 PP:3189-3191
  8. Ilxomova K.A., Abduazizova N.Kh., Kasimova M.B., Agzamova G.S.  Оptimization of methods of basic treatment of early rheumatoid arthritis //American journal of medicine and medical sciences 2021, 11(3): 165-169Doi: 10.5923/j.ajmms.20211103.01
  9. Curtis J.R., John A., Baser O. Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapy. //Arthritis Care Res. 2012; 64(9):1282–1291. doi:10.1002/acr.21693. [PMC free article] [PubMed] [Google Scholar].
  10. Leung B.P., Sattar N., Crilly A. et al. A novel anti-inflammatory role for simvastatin in inflammatory arthritis. //J Immunol 2003; 170: 1524–1530.
  11. McCarey D.W., McInnes I.B., Madhok R. et al. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double blind, randomized placebo-controlled trial. Lancet 2004; 363:2015–2021.

file

download